John Nuss, Chief Scientific Officer at Ventyx Biosciences, Inc. (VTYX), sold 20,000 shares at $38.21 ($773K) on 2023-05-03, disclosed to the SEC on 2023-05-04.
Open-market sale of $773k VTYX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.21 | 4,105 | $157K | 20.3% |
| 2 | $38.21 | 4,105 | $157K | 20.3% |
| 3 | $38.93 | 5,895 | $229K | 29.7% |
| 4 | $38.93 | 5,895 | $229K | 29.7% |
| Total | $38.63 avg | 20,000 | $773K | 100% |
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |